Advertisement

Topics

Cytokinetics Company Profile

01:48 EST 11th December 2018 | BioPortfolio

Cytokinetics is focused on the complementary missions of drug discovery and the commercialization of novel cellular bioinformatics technologies. Cytokinetics drug discovery programs are exploiting the field of cytoskeletal pharmacology for the identification of entirely novel classes of therapeutic compounds. Cytokinetics cellular bioinformatics technologies, called Cytometrix™, are designed to increase the productivity and accelerate the speed of pharmaceutical discovery and development. Synergies generated by these two program areas have allowed Cytokinetics to move at a rapid pace toward the characterization of novel small molecule therapeutics.

Location

280 East Grand Avenue, Suite #2
South San Francisco
CA
94080
United States of America

Contact

Phone: 650 624 3000
Fax: 650 624 3010
Email: hr@cytokinetics.com


News Articles [21 Associated News Articles listed on BioPortfolio]

Cytokinetics ends FORTITUDE-ALS trial enrolment

Cytokinetics has completed patient enrolment in the Phase II FORTITUDE-ALS trial of reldesemtiv (formerly CK-2127107) for the treatment of amyotrophic...Read More... The post Cytokinetics ends FORTITU...

Cytokinetics doses first subject in Phase I CK-274 trial

Cytokinetics has dosed the first subject in a Phase I trial evaluating the safety and tolerability of CK-3773274 (CK-274) to...Read More... The post Cytokinetics doses first subject in Phase I CK-274 ...

Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274

Cytokinetics (Nasdaq:CYTK) announced the first subject has been dosed in a Phase 1 double-blind, randomized, placebo-controlled, multi-part, single and multiple ascending dose clinical trial of CK-377...

Cytokinetics Reports Second Quarter 2018 Financial Results

Cytokinetics (NASDAQ:CYTK) has announced its financial results for Q2 2018. As quoted in the press release: Net loss for the second quarter was $27.5 million, or $0.51 per share, compared to a net los...

Cytokinetics’ Spinal Muscular Atrophy Drug Shows Promise in Phase II

Cytokinetics released data from its Phase II clinical trial of reldesemtiv in patients with spinal muscular atrophy (SMA).

Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program

Cytokinetics (Nasdaq:CYTK) and Astellas Pharma (TSE:4503) today provided an update for their collaborative skeletal muscle program, including clinical trial updates for reldesemtiv in neuromuscular ...

Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy

SOUTH SAN FRANCISCO, Calif., June 16, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced data from the Phase 2 clinical study of reldesemtiv in patients with spinal musc...

Cytokinetics' reldesemtiv misses COPD, frailty endpoints

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma

A single arm, open-label pilot study is designed to determine the safety, efficacy and cytokinetics of CAR-BCMA T cells in patients with BCMA-positive refractory or relapsed multiple myelo...

Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma

A single arm, open-label pilot study is designed to determine the safety, efficacy and cytokinetics of CAR-BCMA T cells in patients with BCMA-positive refractory or relapsed multiple myelo...

A Study of SB-743921 in Non-Hodgkin's Lymphoma

Cytokinetics' CY 2121 Study is an early-phase trial arranged into two phases. The objectives of the first phase of the study are to assess the safety, tolerability and to identify the max...

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

A single arm, open-label pilot study is designed to determine the safety, efficacy and cytokinetics of CAR T cells in patients with malignant tumors with positive antigen targets. CAR T c...

Companies [0 Results]

None

More Information about "Cytokinetics" on BioPortfolio

We have published hundreds of Cytokinetics news stories on BioPortfolio along with dozens of Cytokinetics Clinical Trials and PubMed Articles about Cytokinetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cytokinetics Companies in our database. You can also find out about relevant Cytokinetics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record